Shulin Zhao

State Key Laboratory Of Oncogenes And Related Genes
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

New-Onset Type 2 Diabetes Mellitus and Cancer Risk: A Matched Cohort Study in China Kadoorie Biobank.

New-Onset Type 2 Diabetes Mellitus and Cancer Risk: A Matched Cohort Study in China Kadoorie Biobank.

Journal: International journal of cancer
Published: February 02, 2026

Prognostic and Predictive Values of Transcriptomic Signatures in Metastatic Pancreatic Cancer: A Biomarker Analysis of Three French Multicenter Prospective Randomized Controlled Phase 2 Trials (Prodige35, Prodige37 and AFUGEM).

Prognostic and Predictive Values of Transcriptomic Signatures in Metastatic Pancreatic Cancer: A Biomarker Analysis of Three French Multicenter Prospective Randomized Controlled Phase 2 Trials (Prodige35, Prodige37 and AFUGEM).

Journal: Cancer letters
Published: January 23, 2026

Trends in cancer incidence and mortality in the process of metropolitanization of Shanghai, 1973-2017.

Trends in cancer incidence and mortality in the process of metropolitanization of Shanghai, 1973-2017.

Journal: Frontiers in oncology
Published: April 21, 2025

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings.

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings.

Journal: Nature communications
Published: October 28, 2024

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

Journal: British journal of cancer
Published: July 23, 2024

Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma.

Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma.

Journal: Nature medicine
Published: April 27, 2023

Robotic versus open pancreatoduodenectomy in patients with pancreatic duct adenocarcinoma after the learning curve: a propensity score-matched analysis.

Robotic versus open pancreatoduodenectomy in patients with pancreatic duct adenocarcinoma after the learning curve: a propensity score-matched analysis.

Journal: Surgical endoscopy
Published: April 13, 2023

Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling.

Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling.

Journal: Theranostics
Published: April 05, 2023

Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer.

Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer.

Journal: Frontiers in immunology
Published: November 03, 2022

Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective, propensity score-matched cohort study of 1312 patients.

Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective, propensity score-matched cohort study of 1312 patients.

Journal: Cancer medicine
Published: August 15, 2022

Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.

Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.

Journal: Nature communications
Published: April 14, 2022

BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma.

BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma.

Journal: Clinics and research in hepatology and gastroenterology
Published: October 28, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026